Home Stocks CATX Perspective Therapeutics Inc. (NYSE American: CATX) Healthcare · Medical Devices
$0.78 −0.08 (−9.29%)
Last close · Nov 18, 2026 · NYSE American USD
The Quantellect read. CATX fell 9.29% in the Nov 18 session to $0.78, which is 86.2% below its 52-week high of $5.65. Short interest is 11.59% of float with a 0.53% borrow fee. Ten active firms cover the stock as of Nov 18, 2026; one active firm with a target averages $11.00 over 12 months, and the next earnings report is due Mar 15, 2027. Descriptive summary of the data on this page, not a recommendation.
Relative valuation Mixed valuation signals P/S 517.7× vs peer median 2.7×
Momentum Oversold RSI (14) 29.7 (overbought above 70, oversold below 30) · as of Nov 17, 2026
Trend Below both averages $0.86 vs $2.02 and $3.41 · as of Nov 17, 2026
Short interest 11.6% of float FINRA settlement Oct 30, 2026
SMA 10 $0.85 SMA 20 $1.13 SMA 50 $2.02 SMA 200 $3.41
Nov 17, 2026 O $0.92 H $0.94 L $0.81 C $0.86 Vol 2.79M
×
Chart loads when this section enters view.
Dated chart events require JavaScript on this compact chart. Open the full chart for dated events .
Text price and event history 6M plotted price range (ET) Range 6M First date May 18, 2026 ET Last date Nov 17, 2026 ET Open $3.82 High $4.34 Low $0.78 Close $0.86 Volume 277,294,564 Plotted bars 128
Plotted OHLCV bars May 18, 2026 ET · Open $3.82 · High $3.87 · Low $3.68 · Close $3.76 · Volume 1,111,644 May 19, 2026 ET · Open $3.72 · High $3.75 · Low $3.59 · Close $3.63 · Volume 882,210 May 20, 2026 ET · Open $3.64 · High $3.81 · Low $3.63 · Close $3.77 · Volume 825,761 May 21, 2026 ET · Open $3.70 · High $3.97 · Low $3.66 · Close $3.87 · Volume 918,676 May 22, 2026 ET · Open $3.93 · High $4.11 · Low $3.91 · Close $3.98 · Volume 1,717,408 May 26, 2026 ET · Open $4.03 · High $4.22 · Low $3.93 · Close $4.16 · Volume 1,521,864 May 27, 2026 ET · Open $4.16 · High $4.34 · Low $4.12 · Close $4.16 · Volume 1,029,190 May 28, 2026 ET · Open $4.14 · High $4.24 · Low $4.02 · Close $4.05 · Volume 1,255,009 May 29, 2026 ET · Open $4.06 · High $4.15 · Low $3.90 · Close $3.94 · Volume 893,573 Jun 1, 2026 ET · Open $3.91 · High $4.06 · Low $3.65 · Close $3.66 · Volume 1,479,030 Jun 2, 2026 ET · Open $3.64 · High $3.71 · Low $3.56 · Close $3.60 · Volume 1,006,264 Jun 3, 2026 ET · Open $3.60 · High $3.69 · Low $3.53 · Close $3.56 · Volume 982,179 Jun 4, 2026 ET · Open $3.55 · High $3.63 · Low $3.16 · Close $3.25 · Volume 3,630,013 Jun 5, 2026 ET · Open $3.25 · High $3.29 · Low $3.01 · Close $3.03 · Volume 1,858,810 Jun 8, 2026 ET · Open $3.10 · High $3.13 · Low $2.90 · Close $2.93 · Volume 1,263,134 Jun 9, 2026 ET · Open $2.96 · High $3.04 · Low $2.85 · Close $3.00 · Volume 1,491,131 Jun 10, 2026 ET · Open $2.98 · High $3.06 · Low $2.91 · Close $2.95 · Volume 1,141,452 Jun 11, 2026 ET · Open $3.00 · High $3.04 · Low $2.92 · Close $2.97 · Volume 1,052,849 Jun 12, 2026 ET · Open $2.94 · High $3.02 · Low $2.94 · Close $2.95 · Volume 1,027,229 Jun 15, 2026 ET · Open $3.00 · High $3.13 · Low $2.87 · Close $2.94 · Volume 1,758,437 Jun 16, 2026 ET · Open $2.97 · High $3.00 · Low $2.91 · Close $2.93 · Volume 765,604 Jun 17, 2026 ET · Open $2.95 · High $3.07 · Low $2.94 · Close $2.98 · Volume 2,046,670 Jun 18, 2026 ET · Open $3.02 · High $3.13 · Low $2.93 · Close $2.95 · Volume 7,664,662 Jun 22, 2026 ET · Open $3.00 · High $3.12 · Low $2.95 · Close $3.05 · Volume 2,350,461 Jun 23, 2026 ET · Open $2.99 · High $3.15 · Low $2.99 · Close $3.00 · Volume 1,364,163 Jun 24, 2026 ET · Open $3.00 · High $3.08 · Low $2.90 · Close $3.00 · Volume 1,690,057 Jun 25, 2026 ET · Open $3.00 · High $3.08 · Low $2.97 · Close $3.00 · Volume 1,685,066 Jun 26, 2026 ET · Open $3.00 · High $3.15 · Low $2.94 · Close $3.04 · Volume 9,700,806 Jun 29, 2026 ET · Open $3.05 · High $3.56 · Low $3.00 · Close $3.55 · Volume 1,748,619 Jun 30, 2026 ET · Open $3.59 · High $3.69 · Low $3.39 · Close $3.41 · Volume 2,180,466 Jul 1, 2026 ET · Open $3.42 · High $3.60 · Low $3.42 · Close $3.46 · Volume 1,722,445 Jul 2, 2026 ET · Open $3.50 · High $3.78 · Low $3.46 · Close $3.63 · Volume 1,591,089 Jul 6, 2026 ET · Open $3.62 · High $3.77 · Low $3.57 · Close $3.61 · Volume 1,345,671 Jul 7, 2026 ET · Open $3.66 · High $3.70 · Low $3.37 · Close $3.42 · Volume 1,880,308 Jul 8, 2026 ET · Open $3.38 · High $3.52 · Low $3.33 · Close $3.39 · Volume 2,114,762 Jul 9, 2026 ET · Open $3.39 · High $3.43 · Low $3.15 · Close $3.17 · Volume 3,140,788 Jul 10, 2026 ET · Open $3.18 · High $3.19 · Low $2.90 · Close $3.01 · Volume 2,814,320 Jul 13, 2026 ET · Open $2.97 · High $3.11 · Low $2.82 · Close $3.09 · Volume 3,848,610 Jul 14, 2026 ET · Open $3.09 · High $3.15 · Low $2.94 · Close $3.05 · Volume 2,810,123 Jul 15, 2026 ET · Open $3.08 · High $3.23 · Low $3.01 · Close $3.22 · Volume 1,481,967 Jul 16, 2026 ET · Open $3.17 · High $3.20 · Low $2.91 · Close $2.95 · Volume 1,479,409 Jul 17, 2026 ET · Open $2.93 · High $3.01 · Low $2.88 · Close $2.99 · Volume 1,003,836 Jul 20, 2026 ET · Open $2.99 · High $3.03 · Low $2.88 · Close $2.92 · Volume 915,956 Jul 21, 2026 ET · Open $2.95 · High $3.02 · Low $2.92 · Close $2.98 · Volume 873,942 Jul 22, 2026 ET · Open $2.96 · High $3.03 · Low $2.91 · Close $2.97 · Volume 1,151,847 Jul 23, 2026 ET · Open $2.94 · High $2.98 · Low $2.85 · Close $2.95 · Volume 582,707 Jul 24, 2026 ET · Open $2.97 · High $3.00 · Low $2.90 · Close $2.91 · Volume 671,334 Jul 27, 2026 ET · Open $2.95 · High $3.02 · Low $2.82 · Close $2.82 · Volume 812,765 Jul 28, 2026 ET · Open $2.81 · High $2.89 · Low $2.69 · Close $2.87 · Volume 999,899 Jul 29, 2026 ET · Open $2.87 · High $2.93 · Low $2.77 · Close $2.87 · Volume 1,038,282 Jul 30, 2026 ET · Open $2.89 · High $3.00 · Low $2.87 · Close $2.99 · Volume 622,019 Jul 31, 2026 ET · Open $3.00 · High $3.04 · Low $2.83 · Close $2.91 · Volume 827,649 Aug 3, 2026 ET · Open $2.92 · High $3.03 · Low $2.86 · Close $3.01 · Volume 871,968 Aug 4, 2026 ET · Open $3.01 · High $3.12 · Low $2.98 · Close $3.00 · Volume 2,292,441 Aug 5, 2026 ET · Open $3.00 · High $3.16 · Low $2.92 · Close $2.94 · Volume 1,705,763 Aug 6, 2026 ET · Open $2.97 · High $3.06 · Low $2.94 · Close $2.97 · Volume 503,364 Aug 7, 2026 ET · Open $3.03 · High $3.06 · Low $2.94 · Close $3.00 · Volume 1,045,838 Aug 10, 2026 ET · Open $3.00 · High $3.06 · Low $2.94 · Close $3.00 · Volume 915,894 Aug 11, 2026 ET · Open $3.05 · High $3.25 · Low $2.99 · Close $3.18 · Volume 1,803,759 Aug 12, 2026 ET · Open $3.18 · High $3.28 · Low $3.11 · Close $3.26 · Volume 1,185,900 Aug 13, 2026 ET · Open $3.26 · High $3.28 · Low $3.09 · Close $3.10 · Volume 1,318,924 Aug 14, 2026 ET · Open $3.09 · High $3.23 · Low $3.03 · Close $3.20 · Volume 1,000,183 Aug 17, 2026 ET · Open $3.21 · High $3.31 · Low $3.19 · Close $3.22 · Volume 1,168,261 Aug 18, 2026 ET · Open $3.21 · High $3.25 · Low $3.13 · Close $3.21 · Volume 757,950 Aug 19, 2026 ET · Open $3.31 · High $3.50 · Low $3.30 · Close $3.48 · Volume 1,751,656 Aug 20, 2026 ET · Open $3.46 · High $3.56 · Low $3.18 · Close $3.21 · Volume 1,180,738 Aug 21, 2026 ET · Open $3.25 · High $3.44 · Low $3.22 · Close $3.30 · Volume 1,135,281 Aug 24, 2026 ET · Open $3.32 · High $3.37 · Low $3.13 · Close $3.19 · Volume 678,656 Aug 25, 2026 ET · Open $3.22 · High $3.33 · Low $3.20 · Close $3.29 · Volume 773,771 Aug 26, 2026 ET · Open $3.28 · High $3.30 · Low $3.14 · Close $3.16 · Volume 799,217 Aug 27, 2026 ET · Open $3.15 · High $3.24 · Low $3.10 · Close $3.18 · Volume 797,531 Aug 28, 2026 ET · Open $3.16 · High $3.17 · Low $3.08 · Close $3.11 · Volume 913,335 Aug 31, 2026 ET · Open $3.11 · High $3.18 · Low $3.08 · Close $3.16 · Volume 910,730 Sep 1, 2026 ET · Open $3.16 · High $3.17 · Low $3.07 · Close $3.10 · Volume 705,838 Sep 2, 2026 ET · Open $3.10 · High $3.24 · Low $3.03 · Close $3.10 · Volume 864,638 Sep 3, 2026 ET · Open $3.09 · High $3.14 · Low $3.03 · Close $3.12 · Volume 931,703 Sep 4, 2026 ET · Open $3.07 · High $3.18 · Low $3.03 · Close $3.13 · Volume 1,365,189 Sep 8, 2026 ET · Open $3.12 · High $3.18 · Low $3.02 · Close $3.12 · Volume 1,061,381 Sep 9, 2026 ET · Open $3.07 · High $3.11 · Low $2.96 · Close $2.99 · Volume 1,499,216 Sep 10, 2026 ET · Open $2.96 · High $3.01 · Low $2.75 · Close $2.77 · Volume 1,582,652 Sep 11, 2026 ET · Open $2.77 · High $2.83 · Low $2.67 · Close $2.81 · Volume 2,024,744 Sep 14, 2026 ET · Open $2.81 · High $2.96 · Low $2.79 · Close $2.92 · Volume 2,024,407 Sep 15, 2026 ET · Open $2.88 · High $2.89 · Low $2.66 · Close $2.73 · Volume 1,474,352 Sep 16, 2026 ET · Open $2.73 · High $2.75 · Low $2.62 · Close $2.70 · Volume 1,582,357 Sep 17, 2026 ET · Open $2.76 · High $2.92 · Low $2.74 · Close $2.88 · Volume 1,168,195 Sep 18, 2026 ET · Open $2.89 · High $2.94 · Low $2.77 · Close $2.88 · Volume 11,636,161 Sep 21, 2026 ET · Open $2.94 · High $3.03 · Low $2.90 · Close $2.97 · Volume 2,111,840 Sep 22, 2026 ET · Open $3.00 · High $3.02 · Low $2.81 · Close $2.96 · Volume 5,145,236 Sep 23, 2026 ET · Open $2.89 · High $2.92 · Low $2.50 · Close $2.62 · Volume 3,161,056 Sep 24, 2026 ET · Open $2.58 · High $2.59 · Low $2.44 · Close $2.50 · Volume 1,698,409 Sep 25, 2026 ET · Open $2.50 · High $2.53 · Low $2.45 · Close $2.52 · Volume 1,801,824 Sep 28, 2026 ET · Open $2.50 · High $2.58 · Low $2.46 · Close $2.50 · Volume 1,504,853 Sep 29, 2026 ET · Open $2.52 · High $2.62 · Low $2.49 · Close $2.62 · Volume 1,542,351 Sep 30, 2026 ET · Open $2.64 · High $2.78 · Low $2.55 · Close $2.75 · Volume 1,670,313 Oct 1, 2026 ET · Open $2.71 · High $2.78 · Low $2.66 · Close $2.72 · Volume 1,542,531 Oct 2, 2026 ET · Open $2.77 · High $2.82 · Low $2.69 · Close $2.76 · Volume 2,622,136 Oct 5, 2026 ET · Open $2.75 · High $2.82 · Low $2.48 · Close $2.57 · Volume 3,560,749 Oct 6, 2026 ET · Open $2.59 · High $2.60 · Low $2.30 · Close $2.36 · Volume 2,702,852 Oct 7, 2026 ET · Open $2.37 · High $2.51 · Low $2.32 · Close $2.46 · Volume 1,285,777 Oct 8, 2026 ET · Open $2.43 · High $2.73 · Low $2.37 · Close $2.71 · Volume 3,255,036 Oct 9, 2026 ET · Open $2.71 · High $2.76 · Low $2.63 · Close $2.66 · Volume 1,104,732 Oct 12, 2026 ET · Open $2.61 · High $2.67 · Low $2.51 · Close $2.52 · Volume 640,582 Oct 13, 2026 ET · Open $2.50 · High $2.52 · Low $2.25 · Close $2.27 · Volume 1,309,910 Oct 14, 2026 ET · Open $2.36 · High $2.36 · Low $2.21 · Close $2.24 · Volume 1,394,498 Oct 15, 2026 ET · Open $2.27 · High $2.37 · Low $2.23 · Close $2.34 · Volume 1,189,876 Oct 16, 2026 ET · Open $2.34 · High $2.34 · Low $2.15 · Close $2.17 · Volume 1,669,659 Oct 19, 2026 ET · Open $2.20 · High $2.25 · Low $2.15 · Close $2.19 · Volume 1,138,613 Oct 20, 2026 ET · Open $2.19 · High $2.37 · Low $2.19 · Close $2.30 · Volume 1,812,751 Oct 21, 2026 ET · Open $2.32 · High $2.37 · Low $2.28 · Close $2.30 · Volume 1,241,268 Oct 22, 2026 ET · Open $2.25 · High $2.34 · Low $2.22 · Close $2.26 · Volume 967,762 Oct 23, 2026 ET · Open $2.40 · High $2.40 · Low $1.58 · Close $1.61 · Volume 5,613,965 Oct 26, 2026 ET · Open $1.40 · High $1.59 · Low $1.12 · Close $1.21 · Volume 9,622,962 Oct 27, 2026 ET · Open $1.20 · High $1.26 · Low $1.06 · Close $1.19 · Volume 8,739,478 Oct 28, 2026 ET · Open $1.21 · High $1.25 · Low $1.07 · Close $1.25 · Volume 4,593,438 Oct 29, 2026 ET · Open $1.25 · High $1.28 · Low $1.15 · Close $1.17 · Volume 2,215,827 Oct 30, 2026 ET · Open $1.12 · High $1.15 · Low $1.09 · Close $1.15 · Volume 2,309,335 Nov 2, 2026 ET · Open $1.15 · High $1.19 · Low $1.03 · Close $1.04 · Volume 2,112,340 Nov 3, 2026 ET · Open $1.05 · High $1.08 · Low $0.88 · Close $0.88 · Volume 8,454,344 Nov 4, 2026 ET · Open $0.90 · High $0.96 · Low $0.84 · Close $0.87 · Volume 6,939,125 Nov 5, 2026 ET · Open $0.86 · High $0.88 · Low $0.78 · Close $0.79 · Volume 3,841,191 Nov 6, 2026 ET · Open $0.79 · High $0.91 · Low $0.79 · Close $0.84 · Volume 3,135,348 Nov 9, 2026 ET · Open $0.85 · High $0.87 · Low $0.79 · Close $0.86 · Volume 2,936,155 Nov 10, 2026 ET · Open $0.86 · High $0.91 · Low $0.78 · Close $0.79 · Volume 8,468,712 Nov 11, 2026 ET · Open $0.79 · High $0.88 · Low $0.79 · Close $0.83 · Volume 8,790,901 Nov 12, 2026 ET · Open $0.89 · High $0.90 · Low $0.83 · Close $0.84 · Volume 1,962,233 Nov 13, 2026 ET · Open $0.86 · High $0.97 · Low $0.85 · Close $0.94 · Volume 3,184,418 Nov 16, 2026 ET · Open $0.94 · High $1.02 · Low $0.90 · Close $0.92 · Volume 2,308,565 Nov 17, 2026 ET · Open $0.92 · High $0.94 · Low $0.81 · Close $0.86 · Volume 2,787,455 Event records Event records load after the price chart.
Split-adjusted daily prices · Price as of Nov 17, 2026, 8:46 PM ET
Initial 6M price range summary Range 6M First close $3.76 Last close $0.86 High $4.34 Low $0.78 Volume 277,294,564
Open $0.86 Nov 18, 2026 session
Previous close $0.86 Nov 17, 2026 close
Day range $0.78 – $0.87 Nov 18, 2026 session
52-week range $0.78 – $5.65 Through Nov 18, 2026
Volume 2.69M Nov 18, 2026 session
Average volume (30 calendar days, 22 sessions) 4.24M Through Nov 18, 2026
Market cap —
P/E (TTM) negative earnings —
Forward P/E —
EPS (TTM) eps split basis unknown —
Dividend yield data unavailable —
Beta (5-year monthly vs SPY) 2.03
Price history CATX · amex · USD
Last completed session: Nov 17, 2026
Split-adjusted · volume in shares
Missing session: Nov 18, 2026
November 2026 · 12 completed sessions Date Open High Low Close Change Volume Nov 17 0.9238 0.9399 0.8102 0.8599 −0.0639−6.917082% 2,787,455 Open 0.9238 High 0.9399 Low 0.8102 Nov 16 0.94 1.02 0.9001 0.9238 −0.0193−2.046443% 2,308,565 Open 0.94 High 1.02 Low 0.9001 Nov 13 0.8575 0.9661 0.8544 0.9431 +0.1007+11.953941% 3,184,418 Open 0.8575 High 0.9661 Low 0.8544 Nov 12 0.89 0.90 0.8252 0.8424 +0.0172+2.084343% 1,962,233 Open 0.89 High 0.90 Low 0.8252 Nov 11 0.79 0.8838 0.7867 0.8252 +0.0388+4.933876% 8,790,901 Open 0.79 High 0.8838 Low 0.7867 Nov 10 0.8556 0.906 0.7795 0.7864 −0.0692−8.087892% 8,468,712 Open 0.8556 High 0.906 Low 0.7795 Nov 9 0.8457 0.8728 0.79 0.8556 +0.0156+1.857143% 2,936,155 Open 0.8457 High 0.8728 Low 0.79 Nov 6 0.7874 0.907 0.7874 0.84 +0.0516+6.544901% 3,135,348 Open 0.7874 High 0.907 Low 0.7874 Nov 5 0.86 0.8836 0.7814 0.7884 −0.0818−9.400138% 3,841,191 Open 0.86 High 0.8836 Low 0.7814 Nov 4 0.8966 0.964 0.8373 0.8702 −0.0098−1.113636% 6,939,125 Open 0.8966 High 0.964 Low 0.8373 Nov 3 1.05 1.075 0.8759 0.88 −0.16−15.384615% 8,454,344 Open 1.05 High 1.075 Low 0.8759 Nov 2 1.15 1.185 1.03 1.04 −0.11−9.565217% 2,112,340 Open 1.15 High 1.185 Low 1.03
Notable price movement Sessions where the close moved at least twice its average daily move of the prior 20 sessions (minimum 3%), or 10% or more.
Nov 13
$0.94 +11.95%
Trading volume was 0.8 times the 30-day average, with 3.18M shares traded.
Nov 3
$0.88 −15.38%
Trading volume was 3.0 times the 30-day average, with 8.45M shares traded.
Oct 26
$1.21 −24.84%
Trading volume was 5.1 times the 30-day average, with 9.62M shares traded.
Options flow — · Options flow not available
Q Score 1 /100 Poor
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Liquidity 38 Short 25 Squeeze Not scored Trend 5 Momentum 5 Valuation 48 Stability 13 What each one means Liquidity 38
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short 25
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend 5
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum 5
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation 48
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability 13
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → How CATX compares with its industry Against 139 other US-listed Medical Devices stocks
Dot = rank among peers, low to high · tick = peer median · colour marks the top and bottom 10%
Strongest pointsCurrent ratio was 5.18, higher than 81% of 130 peers.Peer median 2.95 · As of Nov 17, 2026 Points of cautionLatest-quarter year-over-year sales growth was -90.4%, with only 0% of 139 peers reporting a lower value.Peer median 9.3% · As of Nov 17, 2026 One-month return was -60.7%, with only 3% of 135 peers reporting a lower value.Peer median −7.5% · As of Nov 16, 2026 Valuation Mixed valuation signals
Metric CATX Peer median
Profitability Profitability metrics are mixed versus peers.
Metric CATX Peer median
Gross margin — 58.7%
Not ranked: only 127 of 139 peers report it
Operating margin — −3.6%
Not ranked: only 125 of 139 peers report it
Net margin 0.0% −3.5%
Higher than 53% of 137 peers
Return on equity −45.9% −30.0%
Higher than 45% of 133 peers
Growth Growth metrics are lower than most peers.
Metric CATX Peer median
Quarterly sales growth, year over year −90.4% 9.3%
Lowest of 139 peers Higher than 0% of 139 peers
5-year sales growth rate — 16.0%
Not ranked: only 86 of 139 peers report it
Balance sheet Balance sheet metrics are higher than most peers.
Metric CATX Peer median
Momentum Returns are lower than most peers.
Metric CATX Peer median
1-year return −58.7% −17.6%
Higher than 24% of 123 peers
6-month return −76.3% −5.8%
Bottom 10% of peers Higher than 10% of 127 peers
3-month return −75.3% −15.8%
Bottom 10% of peers Higher than 6% of 133 peers
How to read this The dot marks where CATX ranks among its peers on each metric, from lowest (left) to highest (right). The tick in the middle marks the peer median.
Green marks a rank in the top 10% of peers, amber the bottom 10%. Valuation and balance-sheet metrics stay neutral because a high rank there is not better or worse.
A metric is ranked only when enough peers report it. Peers exclude this company. Percentages count peers with a strictly lower value; equal values do not count.
Lowest Median Highest
Compared with 139 other US-listed Medical Devices stocks · fundamentals as of Nov 18, 2026 · prices as of Nov 13, 2026
Analyst consensus Buy
0 Strong Buy
9 Buy
1 Neutral
0 Sell
0 Strong Sell
Based on 10 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $11.00
Average $11.00
High $11.00
As of Nov 18, 2026 across 1 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −1.50 −1.00 −0.50 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.25 −$0.27 —
Q2 2026 −$0.27 −$0.22 —
Q1 2026 — −$0.25 —
Annual 2025 −$0.35 −$1.40 —
Q3 2025 — −$0.35 —
Q2 2025 — −$0.29 —
Q1 2025 — −$0.25 —
Annual 2024 −$0.27 −$1.23 —
Next: Mar 15, 2027, estimate −$0.26
Smart-money activity In the last 60 days: 0 insider sales and 9 purchases. Last quarter: 0 new 13F positions. No congressional trades in 90 days.
Date Type Who Action Amount Source
Nov 17, 2026 Insider buy Williamson Robert F III Buy $21.0K Form 4 Nov 16, 2026 Insider buy Morich Frank Buy $14.0K Form 4 Nov 12, 2026 Insider buy Morich Frank Buy $15.0K Form 4 Nov 12, 2026 Insider buy Williamson Robert F III Buy $5.3K Form 4 Nov 12, 2026 Insider buy Williamson Robert F III Buy $15.6K Form 4 Nov 12, 2026 Insider buy Woods Lori A Buy $20.0K Form 4 Nov 12, 2026 Insider buy Puhlmann Markus Buy $29.6K Form 4 Nov 11, 2026 Insider buy Puhlmann Markus Buy $5.0K Form 4 Nov 11, 2026 Insider buy Spoor Johan M. Buy $37.9K Form 4 Sep 4, 2026 Insider sell Lantheus Alpha Therapy, LLC / Lantheus Holdings, Inc. Sell $526.1K Form 4 All smart-money activity →
News and press releases Year All 2026 2025 2024 Oct 8, 2026, 6:16 AM ET Oct 7, 2026, 6:16 AM ET Oct 2, 2026, 11:46 AM ET Sep 14, 2026, 6:16 AM ET Sep 11, 2026, 6:00 AM ET Aug 10, 2026, 4:22 PM ET Jul 31, 2026, 6:30 AM ET Jul 28, 2026, 6:30 AM ET Jul 17, 2026, 12:22 PM ET Jul 8, 2026, 6:30 AM ET All CATX news → Company profile Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a
CEO Mr. Johan M. Spoor
Headquarters Seattle, WA, United States
Employees 163
IPO date Nov 10, 2005
Sector Healthcare
Industry Medical Devices Q Score 1 /100 Poor
Latest available: Nov 13, 2026 · updates irregularly
Each axis is a 0 to 100 percentile rank among equities
Liquidity 38 Short 25 Squeeze Not scored Trend 5 Momentum 5 Valuation 48 Stability 13 What each one means Liquidity 38
Higher scores reflect greater average dollar trading volume and less absolute return per dollar traded over 21 sessions within equity peers.
Short 25
Higher scores reflect less short-interest pressure relative to trading volume and the company's own history, and less growth in shares short, within equity peers.
Squeeze Not scored
Higher scores reflect a higher published Squeeze score within equity peers.
Trend 5
Higher scores reflect a price nearer its 252-session split-adjusted closing high and positive 63- and 126-session total returns.
Momentum 5
Higher scores reflect stronger 63- and 126-session total returns within equity peers.
Valuation 48
Higher scores reflect lower positive P/E, P/B, EV/EBITDA and price/sales multiples within equity peers; limited data pulls the score toward neutral.
Stability 13
Higher scores reflect lower daily total-return volatility over 63 and 252 sessions within equity peers.
How the Q Score works → Analyst consensus Buy
0 Strong Buy
9 Buy
1 Neutral
0 Sell
0 Strong Sell
Based on 10 active firms as of Nov 18, 2026 (365-day activity window)
12-month price targets (third-party analysts) Low $11.00
Average $11.00
High $11.00
As of Nov 18, 2026 across 1 active firms with targets. Targets are published by third-party analysts, not by Quantellect.
Full analyst forecast →
Earnings history EPS, last 8 quarters −1.50 −1.00 −0.50 0.00 FY ’24 Q1 ’25 Q2 ’25 Q3 ’25 FY ’25 Q1 ’26 Q2 ’26 Q3 ’26
Estimate Beat Miss Match
Fiscal period Est. Actual Result
Q3 2026 −$0.25 −$0.27 —
Q2 2026 −$0.27 −$0.22 —
Q1 2026 — −$0.25 —
Annual 2025 −$0.35 −$1.40 —
Q3 2025 — −$0.35 —
Q2 2025 — −$0.29 —
Q1 2025 — −$0.25 —
Annual 2024 −$0.27 −$1.23 —
Next: Mar 15, 2027, estimate −$0.26
Company profile Perspective Therapeutics, Inc., a radiopharmaceutical development company, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. It discovers and develops its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a
CEO Mr. Johan M. Spoor
Headquarters Seattle, WA, United States
Employees 163
IPO date Nov 10, 2005
Sector Healthcare
Industry Medical Devices